Revision sistemática sobre la implantación y la evaluación del seguimiento farmacoterapéutico en pacientes hospitalizados

Castro, Martha Milena Silva; Valls, Laura Tuneu i; Faus, María José

doi:10.1016/j.farma.2009.09.007

Cited by 9 publications

(6 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…These achievements evidence the pharmacist as a professional for insertion into health teams in Brazil [ 19 , 20 ]. This setting in health care allowed the pharmacist to be inserted into the Brazilian Hypertension Guidelines in collaboration with multidisciplinary care of hypertensive patients [ 4 , 21 ]. However, public health policies do not have a guideline or a consolidated model for the development of PC in the PHS.…”

Section: Introductionmentioning

confidence: 99%

Impact Assessment of Pharmaceutical Care in the Management of Hypertension and Coronary Risk Factors after Discharge

et al. 2016

View full text Add to dashboard Cite

IntroductionAlmost 50% of the 17.5 million deaths worldwide from cardiovascular disease have been associated with systemic arterial hypertension (SAH). Into this scenario, Pharmaceutical Care (PC) has been inserted in order to improve the management of SAH and reduce its risks.ObjectiveTo evaluate the outcomes and healthcare assistance achieved after discharge of hypertension patients from the PC program.MethodsThis is a quasi-experimental study with historical controls. Retrospective data collection from 2006 to 2012 was begun in 2013 and included a PC program performed over one year. PC was performed in two basic units of the public health system in Ribeirão Preto-SP, Brazil, where the pharmacist followed up 104 hypertensive patients. The clinical indicators of systolic (SBP) and diastolic blood pressure (DBP), triglycerides, total-cholesterol, high and low density lipoprotein cholesterol were collected, as well as care indicators related to the number of consultations (basic, specialized and emergency care) and antihypertensive drugs used. The coronary risk of patients by the Framingham risk score was also calculated. For the analysis, the data were divided into three periods, 2006–2008 as pre-PC, 2009 as PC and 2010–2012 as post-PC.ResultsIn the pre-PC period, 54.4%, 79.0% and 27.3% of patients presented satisfactory levels of SBP, DBP and total-cholesterol, respectively. In the post-PC period, the percentages were 93.0% for SBP and DBP [p <0.001] and 60.6% for total-cholesterol [p <0.001]. The average number of consultations per patient/year in primary care was 1.66 ± 1.43 and 2.36 ± 1.73, [p = 0.012]; and for emergency care was 1.70 ± 1.43 and 1.06 ± 0.81, [p = 0.002] in the pre-PC and post-PC periods, respectively. The pre-PC Framingham risk in the last year was 14.3% ± 10.6 and the average post-PC was 10.9% ± 7.9.ConclusionPC was effective in the control of blood pressure and total-cholesterolafter discharge of the hypertensive patients from PC program.

show abstract

Section: Introductionmentioning

confidence: 99%

Impact Assessment of Pharmaceutical Care in the Management of Hypertension and Coronary Risk Factors after Discharge

et al. 2016

View full text Add to dashboard Cite

show abstract

“…The persistent morbidity and mortality related to pharmaceutical treatment makes the role of pharmacists essential in the design of strategies that will achieve better results in drug therapy 23. As part of a pharmaceutical care programme, we participate in the education of patients to teach them the objective of the treatment, to be aware of the possible side effects and to understand the importance of good compliance.…”

Section: Discussionmentioning

confidence: 99%

Information leaflets for patients with hepatitis C receiving treatment with triple therapy

et al. 2012

View full text Add to dashboard Cite

The NS3/4 protease inhibitors boceprevir and telaprevir in conjunction with peginterferon α and ribavirin (triple therapy) increase the rate of a sustained virological response in patients with genotype-1 chronic hepatitis C but, to achieve a successful result, good compliance is vital. As part of a pharmaceutical care programme, in the Outpatient Pharmacy we developed information leaflets to help patients understand the objectives of triple therapy, to be aware and prevent the possible side effects and to teach patients how to take the medicines.

show abstract

“…Vale considerar a necessidade atual de que atividades assistenciais, como as previstas nesse componente, sejam realizadas e avaliadas de forma sistêmica e contínua com o objetivo de obtenção de qualidade da assistência com subsequente impacto positivo na qualidade de vida do paciente 48,49 . Além disso, o fato de terem sido excluídos publicações relacionadas especificamente à farmácia clínica pode ter comprometido a inserção de pesquisas com abordagem relacionada ao acompanhamento farmacoterapêutico na amostra.…”

Section: Acompanhamento Farmacoterapêuticounclassified

Evaluation of hospital pharmacy services: an integrative review

Lima¹,

Toledo²,

Naves³

2019

Rev Bras Farm Hosp Serv Saude

View full text Add to dashboard Cite

Background: Pharmaceutical services performed in the hospital context have specific structure and processes, which should be continuously evaluated because they influence the results obtained. Objective: To identify, describe and compare studies of evaluation of pharmaceutical services performed in the hospital context. Methods: Integrative review of articles found in databases SciELO, LILACS, MEDLINE and IBECS, indexed in the period from 2000 to 2016, using the following descriptors: “Hospital Pharmacy Service” and “Evaluation“. The references were analyzed according to year, language, country of publication and type of study and classified according to their focus on the components of the hospital pharmacy service logic model that dealt with the management, selection, programming, acquisition, storage and distribution of medicines, information, pharmacotherapeutic, pharmacotechnical and teaching and research follow-up. Results: Of the 25 publications, 16 (64%) were in the English language, of which 10 (40%) were in the United States; 17 (70%) studies were published from 2010 to 2016 and 13 (52%) were observational descriptive type. The most discussed component of pharmaceutical services was distribution logistics addressed in 15 publications (60%), followed by the management component addressed by 14 (56%) studies. Conclusions: The publications emphasized the discussion on drug logistics. Only a few presented discussions on the impact of these services on health care, such as patient safety. Such studies can support the decision-making process and the formulation of strategies aimed at increasing the management capacity and the quality of the service provided.

show abstract

Revision sistemática sobre la implantación y la evaluación del seguimiento farmacoterapéutico en pacientes hospitalizados

Cited by 9 publications

References 36 publications

Impact Assessment of Pharmaceutical Care in the Management of Hypertension and Coronary Risk Factors after Discharge

Impact Assessment of Pharmaceutical Care in the Management of Hypertension and Coronary Risk Factors after Discharge

Information leaflets for patients with hepatitis C receiving treatment with triple therapy

Evaluation of hospital pharmacy services: an integrative review

Contact Info

Product

Resources

About